Fc gamma RII/RIII (CD32/CD16) Antibody (190909) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB1460H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
HRP
Antibody Source
Recombinant Monoclonal Rat IgG2B Clone # 190909
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse Fc gamma RIIB
Thr30-Arg207
Accession # P08101
Thr30-Arg207
Accession # P08101
Reactivity Notes
0
Specificity
Detects mouse Fc gamma RII/RIII (CD32/CD16) in direct ELISAs and Western blots. In direct ELISAs and Western blots, 100% cross-reactivity with recombinant mouse CD16 is observed and no cross-reactivity with recombinant human CD32 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2B
Applications for Fc gamma RII/RIII (CD32/CD16) Antibody (190909) [HRP]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Fc gamma RII/RIII (CD32/CD16)
Long Name
Fc gamma Receptor II/III
Alternate Names
CD32/CD16
Additional Fc gamma RII/RIII (CD32/CD16) Products
Product Documents for Fc gamma RII/RIII (CD32/CD16) Antibody (190909) [HRP]
Product Specific Notices for Fc gamma RII/RIII (CD32/CD16) Antibody (190909) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...